ICON Public Limited Company (ICLR)
USD 142.96
(-1.55%)
USD 142.96
(-1.55%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.98 Billion USD | -1.14% |
| 2022 | 17.18 Billion USD | -1.16% |
| 2021 | 17.38 Billion USD | 401.68% |
| 2020 | 3.46 Billion USD | 19.2% |
| 2019 | 2.9 Billion USD | 21.84% |
| 2018 | 2.38 Billion USD | 9.17% |
| 2017 | 2.18 Billion USD | 19.72% |
| 2016 | 1.82 Billion USD | 6.22% |
| 2015 | 1.71 Billion USD | 12.51% |
| 2014 | 1.52 Billion USD | 5.92% |
| 2013 | 1.44 Billion USD | 19.69% |
| 2012 | 1.2 Billion USD | 16.39% |
| 2011 | 1.03 Billion USD | 9.05% |
| 2010 | 949.53 Million USD | 4.53% |
| 2009 | 908.39 Million USD | 4.74% |
| 2008 | 867.28 Million USD | 25.12% |
| 2007 | 693.13 Million USD | 45.51% |
| 2006 | 476.34 Million USD | 36.46% |
| 2005 | 349.06 Million USD | 4.1% |
| 2004 | 335.32 Million USD | 42.68% |
| 2003 | 235.01 Million USD | 41.75% |
| 2002 | 165.79 Million USD | 28.56% |
| 2001 | 128.96 Million USD | 28.81% |
| 2000 | 100.11 Million USD | 6.74% |
| 1999 | 93.8 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 17.04 Billion USD | 0.34% |
| 2024 Q3 | 17.21 Billion USD | 1.43% |
| 2024 Q2 | 16.96 Billion USD | -0.47% |
| 2023 Q2 | 17.1 Billion USD | -1.03% |
| 2023 FY | 16.98 Billion USD | -1.14% |
| 2023 Q1 | 17.28 Billion USD | 0.59% |
| 2023 Q4 | 16.98 Billion USD | -0.24% |
| 2023 Q3 | 17.03 Billion USD | -0.45% |
| 2022 Q3 | 17.12 Billion USD | 0.53% |
| 2022 FY | 17.18 Billion USD | -1.16% |
| 2022 Q1 | 17.16 Billion USD | -1.29% |
| 2022 Q2 | 17.03 Billion USD | -0.74% |
| 2022 Q4 | 17.18 Billion USD | 0.35% |
| 2021 FY | 17.38 Billion USD | 401.68% |
| 2021 Q1 | 3.46 Billion USD | 0.02% |
| 2021 Q2 | 3.58 Billion USD | 3.4% |
| 2021 Q3 | 17.65 Billion USD | 392.53% |
| 2021 Q4 | 17.38 Billion USD | -1.51% |
| 2020 Q2 | 2.85 Billion USD | 0.61% |
| 2020 Q1 | 2.84 Billion USD | -2.28% |
| 2020 Q3 | 3.06 Billion USD | 7.23% |
| 2020 Q4 | 3.46 Billion USD | 13.07% |
| 2020 FY | 3.46 Billion USD | 19.2% |
| 2019 Q4 | 2.9 Billion USD | 5.91% |
| 2019 FY | 2.9 Billion USD | 21.84% |
| 2019 Q3 | 2.74 Billion USD | 0.96% |
| 2019 Q1 | 2.6 Billion USD | 9.26% |
| 2019 Q2 | 2.71 Billion USD | 4.29% |
| 2018 Q1 | 2.21 Billion USD | 1.54% |
| 2018 FY | 2.38 Billion USD | 9.17% |
| 2018 Q4 | 2.38 Billion USD | 2.61% |
| 2018 Q3 | 2.32 Billion USD | 6.95% |
| 2018 Q2 | 2.17 Billion USD | -2.03% |
| 2017 Q1 | 1.85 Billion USD | 1.61% |
| 2017 FY | 2.18 Billion USD | 19.72% |
| 2017 Q4 | 2.18 Billion USD | 6.45% |
| 2017 Q3 | 2.05 Billion USD | 7.83% |
| 2017 Q2 | 1.9 Billion USD | 2.65% |
| 2016 FY | 1.82 Billion USD | 6.22% |
| 2016 Q1 | 1.79 Billion USD | 4.49% |
| 2016 Q2 | 1.75 Billion USD | -2.56% |
| 2016 Q3 | 1.9 Billion USD | 8.58% |
| 2016 Q4 | 1.82 Billion USD | -3.93% |
| 2015 Q3 | 1.81 Billion USD | 10.79% |
| 2015 FY | 1.71 Billion USD | 12.51% |
| 2015 Q2 | 1.63 Billion USD | 1.95% |
| 2015 Q1 | 1.6 Billion USD | 5.05% |
| 2015 Q4 | 1.71 Billion USD | -5.18% |
| 2014 Q3 | 1.57 Billion USD | 3.08% |
| 2014 FY | 1.52 Billion USD | 5.92% |
| 2014 Q1 | 1.48 Billion USD | 2.92% |
| 2014 Q4 | 1.52 Billion USD | -2.86% |
| 2014 Q2 | 1.52 Billion USD | 2.78% |
| 2013 Q2 | 1.29 Billion USD | 5.03% |
| 2013 FY | 1.44 Billion USD | 19.69% |
| 2013 Q4 | 1.44 Billion USD | 5.9% |
| 2013 Q3 | 1.36 Billion USD | 5.33% |
| 2013 Q1 | 1.23 Billion USD | 2.42% |
| 2012 FY | 1.2 Billion USD | 16.39% |
| 2012 Q1 | 1.12 Billion USD | 8.7% |
| 2012 Q4 | 1.2 Billion USD | 5.89% |
| 2012 Q3 | 1.13 Billion USD | 2.75% |
| 2012 Q2 | 1.1 Billion USD | -1.83% |
| 2011 Q1 | 1.01 Billion USD | 6.76% |
| 2011 FY | 1.03 Billion USD | 9.05% |
| 2011 Q4 | 1.03 Billion USD | -0.97% |
| 2011 Q3 | 1.04 Billion USD | 3.1% |
| 2011 Q2 | 1.01 Billion USD | 0.06% |
| 2010 Q2 | 888.54 Million USD | -0.95% |
| 2010 Q4 | 949.53 Million USD | 1.25% |
| 2010 FY | 949.53 Million USD | 4.53% |
| 2010 Q1 | 897.1 Million USD | -1.24% |
| 2010 Q3 | 937.85 Million USD | 5.55% |
| 2009 Q2 | 897.47 Million USD | 5.52% |
| 2009 FY | 908.39 Million USD | 4.74% |
| 2009 Q1 | 850.53 Million USD | -1.93% |
| 2009 Q3 | 922.14 Million USD | 2.75% |
| 2009 Q4 | 908.39 Million USD | -1.49% |
| 2008 Q2 | 843.96 Million USD | 5.78% |
| 2008 Q3 | 808.65 Million USD | -4.18% |
| 2008 FY | 867.28 Million USD | 25.12% |
| 2008 Q1 | 797.88 Million USD | 15.11% |
| 2008 Q4 | 867.28 Million USD | 7.25% |
| 2007 FY | 693.13 Million USD | 45.51% |
| 2007 Q1 | 476.13 Million USD | -0.04% |
| 2007 Q4 | 693.13 Million USD | 9.71% |
| 2007 Q3 | 631.78 Million USD | 21.05% |
| 2007 Q2 | 521.92 Million USD | 9.62% |
| 2006 Q1 | 364.45 Million USD | 2.7% |
| 2006 FY | 476.34 Million USD | 36.46% |
| 2006 Q3 | 431.13 Million USD | 9.83% |
| 2006 Q4 | 476.34 Million USD | 10.48% |
| 2006 Q2 | 392.56 Million USD | 7.71% |
| 2005 Q1 | 365.92 Million USD | -1.2% |
| 2005 FY | 349.06 Million USD | 4.1% |
| 2005 Q4 | 354.87 Million USD | 2.39% |
| 2005 Q3 | 346.6 Million USD | -0.27% |
| 2005 Q2 | 347.55 Million USD | -5.02% |
| 2004 Q3 | 341.01 Million USD | 1.7% |
| 2004 Q2 | 335.32 Million USD | 4.75% |
| 2004 Q1 | 320.11 Million USD | 3.71% |
| 2004 FY | 335.32 Million USD | 42.68% |
| 2004 Q4 | 370.36 Million USD | 8.61% |
| 2003 Q1 | 215.04 Million USD | 15.05% |
| 2003 Q3 | 275.73 Million USD | 17.33% |
| 2003 FY | 235.01 Million USD | 41.75% |
| 2003 Q4 | 308.67 Million USD | 11.95% |
| 2003 Q2 | 235.01 Million USD | 9.29% |
| 2002 FY | 165.79 Million USD | 28.56% |
| 2002 Q4 | 186.92 Million USD | 11.93% |
| 2002 Q3 | 166.99 Million USD | 0.73% |
| 2002 Q2 | 165.79 Million USD | 10.38% |
| 2002 Q1 | 150.2 Million USD | 1.27% |
| 2001 Q1 | 116.24 Million USD | 4.85% |
| 2001 Q4 | 148.31 Million USD | 9.68% |
| 2001 FY | 128.96 Million USD | 28.81% |
| 2001 Q3 | 135.22 Million USD | 4.85% |
| 2001 Q2 | 128.96 Million USD | 10.95% |
| 2000 Q1 | 106 Million USD | 6.11% |
| 2000 Q4 | 110.86 Million USD | -5.24% |
| 2000 Q3 | 116.99 Million USD | 16.85% |
| 2000 Q2 | 100.11 Million USD | -5.56% |
| 2000 FY | 100.11 Million USD | 6.74% |
| 1999 Q4 | 99.9 Million USD | 4.28% |
| 1999 FY | 93.8 Million USD | 0.0% |
| 1999 Q2 | 93.8 Million USD | 0.0% |
| 1999 Q3 | 95.8 Million USD | 2.13% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -8506.602% |
| Biodesix, Inc. | 99.09 Million USD | -17044.852% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -206550.314% |
| Castle Biosciences, Inc. | 477.81 Million USD | -3455.771% |
| DarioHealth Corp. | 96.38 Million USD | -17526.351% |
| Exact Sciences Corporation | 6.47 Billion USD | -162.54% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -421.173% |
| Illumina, Inc. | 10.11 Billion USD | -68.033% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -123203.81% |
| iSpecimen Inc. | 15.81 Million USD | -107300.694% |
| Standard BioTools Inc. | 323.06 Million USD | -5158.929% |
| 23andMe Holding Co. | 395.16 Million USD | -4199.413% |
| Medpace Holdings, Inc. | 1.65 Billion USD | -925.445% |
| NeoGenomics, Inc. | 1.68 Billion USD | -910.562% |
| Inotiv, Inc. | 856.53 Million USD | -1883.569% |
| Psychemedics Corporation | 13.27 Million USD | -127932.125% |
| Prenetics Global Limited | 254.17 Million USD | -6584.435% |
| Precipio, Inc. | 18.1 Million USD | -93761.461% |
| RadNet, Inc. | 2.88 Billion USD | -488.558% |
| Sotera Health Company | 3.13 Billion USD | -442.734% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -19434.416% |
| Exagen Inc. | 56.94 Million USD | -29736.09% |
| Natera, Inc. | 1.45 Billion USD | -1065.985% |
| Aspira Women's Health Inc. | 6.26 Million USD | -271216.88% |
| Neogen Corporation | 4.58 Billion USD | -270.621% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -1317.357% |
| Bionano Genomics, Inc. | 214.4 Million USD | -7824.229% |
| CareDx, Inc | 484.61 Million USD | -3405.848% |
| Check-Cap Ltd. | 25.01 Million USD | -67813.271% |
| Twist Bioscience Corporation | 776.4 Million USD | -2088.279% |
| Guardant Health, Inc. | 1.78 Billion USD | -851.056% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -148936.592% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | -1234.518% |
| Sera Prognostics, Inc. | 95.44 Million USD | -17701.43% |
| OPKO Health, Inc. | 2.01 Billion USD | -744.553% |
| Personalis, Inc. | 225.09 Million USD | -7447.729% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -124353.483% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -19434.416% |
| MDxHealth SA | 129.13 Million USD | -13056.973% |
| Prenetics Global Limited | 254.17 Million USD | -6584.435% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -251447.168% |
| Mainz Biomed B.V. | 15.4 Million USD | -110159.148% |
| Trinity Biotech plc | 59.43 Million USD | -28485.62% |
| Neuronetics, Inc. | 115.83 Million USD | -14567.803% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -206550.314% |